How much does AMD treatment cost?
What are the costs of AMD treatment? The costs of treatment for wet age-related macular degeneration include costs of the drug itself and indeed the cost of delivering the injection and the provision of the facility and the drops that we use.
So, AMD treatment costs can vary from patient to patient. I will discuss this with you when I see you in the clinic but typically the treatment – once we’ve factored in all the costs – can vary from approximately £1,000 up to £2,000 per injection and indeed I will tailor the treatment plan based on how you respond to the treatment.
Do you need treatment?
To see whether you need treatment for wet age-related macular degeneration, I’ll initially carry out a consultation to ask you questions about your vision health and your general health, to examine your eye. Then, I’ll carry out tests to determine whether you have age-related macular degeneration and need treatment.
The cost of the consultation is £250, but there may be extra costs based on the test that you need to reach a diagnosis. But I can discuss that with you ahead of time through our reception team.
One way of making sure that the costs of diagnosis as low as possible is through the Macular VisionSafe Check. For those of you not familiar with this, the VisionSafe Check combines a consultation with state-of-the-art diagnostic imaging tests and gives me an opportunity to discuss your retinal imaging tests with you. I can then provide you with a personalised treatment plan and risk assessment regarding macular disease and vision loss.
Whether you opt for treatment in the NHS or privately, the important thing is to make sure you have an accurate diagnosis, a personalised approach to treatment and most importantly, that diagnosis and treatment is undertaken without delay as this post from Healthunlocked illustrates.
A couple of the key messages I took from this webpage was that patients who had been through the process of wet AMD treatment understood the value of seeing a consultant ophthalmologist as soon as they had symptoms of wet age-related macular degeneration and also the importance of early access to treatment.